REVB (Revelation Biosciences) Accounts Payable: $0.83 Mil (As of Mar. 2026)


REVB Revelation Biosciences Inc REVB
28 GF Score
Price $1.06
! 1 Warning Sign
View Full Analysis

What is Revelation Biosciences Accounts Payable?

Revelation Biosciences REVB +1.64% 28 Accounts Payable is $0.83 Mil as of Mar. 2026. GuruFocus rates REVB with a GF Score™ of 28/100. The stock has 1 warning sign investors should review.

Revelation Biosciences's Accounts Payable for the quarter that ended in Mar. 2026 was $0.83 Mil.

Revelation Biosciences's quarterly Accounts Payable declined from Sep. 2025 ($1.04 Mil) to Dec. 2025 ($0.58 Mil) but then increased from Dec. 2025 ($0.58 Mil) to Mar. 2026 ($0.83 Mil).

Revelation Biosciences's annual Accounts Payable declined from Dec. 2023 ($1.36 Mil) to Dec. 2024 ($0.78 Mil) and declined from Dec. 2024 ($0.78 Mil) to Dec. 2025 ($0.58 Mil).

Revelation Biosciences Accounts Payable Related Terms

Revelation Biosciences Accounts Payable Historical Data

* Premium members only.

The historical data trend for Revelation Biosciences's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revelation Biosciences Accounts Payable Chart

Revelation Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 0.60 0.55 1.36 0.78 0.58

Revelation Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 0.83 1.04 0.58 0.83
REVB
28GF Score
Revelation Biosciences Inc REVB
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revelation Biosciences Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.83 Mil mean?
Revelation Biosciences (REVB) has a Accounts Payable of $0.83 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Revelation Biosciences and its competitors.
Is Revelation Biosciences' Accounts Payable too high?
Revelation Biosciences' current Accounts Payable is $0.83 Mil. Overall, Revelation Biosciences has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Revelation Biosciences' Accounts Payable compare to ARTL and ONCO?
Revelation Biosciences' Accounts Payable of $0.83 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Revelation Biosciences and its competitors. Revelation Biosciences's current Accounts Payable is $0.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revelation Biosciences stock overvalued right now?
Revelation Biosciences (REVB) has a current Accounts Payable of $0.83 Mil. The current Accounts Payable is $0.83 Mil. Revelation Biosciences' overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Revelation Biosciences (REVB), the current Accounts Payable is $0.83 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Revelation Biosciences Business Description

Address 4660 La Jolla Village Drive, Suite 100, San Diego, CA, USA, 92122
Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.
28GF Score

Get the complete analysis for REVB

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.06
Price